ELOXATIN for Rectal cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where ELOXATIN was used for Rectal cancer.
Most Reported Side Effects for ELOXATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 14 | 12.7% | 2 | 8 |
| Vomiting | 11 | 10.0% | 1 | 7 |
| Diarrhoea | 10 | 9.1% | 2 | 7 |
| Abdominal pain | 8 | 7.3% | 0 | 8 |
| Chills | 8 | 7.3% | 1 | 3 |
| Dyspnoea | 7 | 6.4% | 2 | 1 |
| Febrile neutropenia | 7 | 6.4% | 1 | 6 |
| Neuropathy peripheral | 7 | 6.4% | 0 | 0 |
| Paraesthesia | 7 | 6.4% | 0 | 1 |
| Pyrexia | 7 | 6.4% | 0 | 4 |
| Anaemia | 6 | 5.5% | 2 | 5 |
| Erythema | 6 | 5.5% | 0 | 1 |
| Blood pressure increased | 5 | 4.6% | 0 | 0 |
| Death | 5 | 4.6% | 5 | 0 |
| Embolism | 5 | 4.6% | 0 | 5 |
Other Indications for ELOXATIN
Colon cancer (20)
Adenocarcinoma of colon (16)
Product used for unknown indication (8)
Pancreatic carcinoma (7)
Other Drugs Used for Rectal cancer
CAPECITABINE (2,976)
OXALIPLATIN (2,402)
FLUOROURACIL (1,610)
BEVACIZUMAB (1,546)
TIPIRACIL\TRIFLURIDINE (1,297)
IRINOTECAN (985)
LEUCOVORIN (660)
CETUXIMAB (542)
REGORAFENIB (505)
PANITUMUMAB (374)